Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price rose 17.6% during mid-day trading on Monday . The company traded as high as C$0.20 and last traded at C$0.20. Approximately 134,500 shares changed hands during trading, a decline of 48% from the average daily volume of 256,409 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Up 5.9 %
The company has a market cap of C$27.27 million, a price-to-earnings ratio of -16.84 and a beta of 0.32. The firm has a 50-day moving average price of C$0.16 and a 200 day moving average price of C$0.10. The company has a debt-to-equity ratio of 4.23, a current ratio of 0.10 and a quick ratio of 0.84.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Profit From Value Investing
- Palantir Setting Up to Be a Big Winner With New Defense Spending
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Advanced Micro Devices Can Double in Price: Here’s Why
- ESG Stocks, What Investors Should Know
- How Disney’s Experiences Segment Can Restore the House of Mouse
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
